Brief: Apogee Therapeutics Announces Closing Of Upsized Public Offering
March 12 (Reuters) - Apogee Therapeutics Inc APGE.O :
* APOGEE THERAPEUTICS, INC. ANNOUNCES CLOSING OF UPSIZED
PUBLIC
OFFERING AND FULL EXERCISE OF THE UNDERWRITERS’ OPTION TO
PURCHASE ADDITIONAL SHARES FOR GROSS PROCEEDS OF $483 MILLION
Source text for Eikon: ID:nGNX4TFmg4
Further company coverage: APGE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Apogee Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Abbvie Seeks At Least $8 Billion In Debt To Fund Apogee Deal - Bloomberg News
Street View: Strength in AbbVie's immunology pipeline to support revenue growth
AbbVie trims 2026 profit view on Apogee deal, tops second-quarter estimates (updated)